ACTA1 and glaucoma: Daily administration of 100 mg/kg CCG-222740 reduced and delayed subconjunctival scarring after glaucoma filtration surgery and improved surgery success by 67%. CCG-203971 delayed slightly less subconjunctival scarring and improved surgery success by 33% compared to a control. Inhibitors decreased cellularity and α-smooth muscle actin (α-SMA expression